Pankaj Mohan - Net Worth and Insider Trading
Pankaj Mohan Net Worth
The estimated net worth of Pankaj Mohan is at least $1 Million dollars as of 2024-05-27. Pankaj Mohan is the Chairman, President and CEO of Sonnet BioTherapeutics Holdings Inc and owns about 620,379 shares of Sonnet BioTherapeutics Holdings Inc (SONN) stock worth over $1 Million. Pankaj Mohan is also the Director, 10% Owner of Outlook Therapeutics Inc and owns about 48,023 shares of Outlook Therapeutics Inc (OTLK) stock worth over $379,382. Details can be seen in Pankaj Mohan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Pankaj Mohan has not made any transactions after 2023-05-15 and currently still holds the listed stock(s).
Transaction Summary of Pankaj Mohan
Pankaj Mohan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pankaj Mohan owns 2 companies in total, including Sonnet BioTherapeutics Holdings Inc (SONN) , and Outlook Therapeutics Inc (OTLK) .
Click here to see the complete history of Pankaj Mohan’s form 4 insider trades.
Insider Ownership Summary of Pankaj Mohan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SONN | Sonnet BioTherapeutics Holdings Inc | 2023-05-15 | director & Chairman & President and CEO |
| OTLK | Outlook Therapeutics Inc | 2019-01-15 | director & 10 percent owner & President & CEO |
Pankaj Mohan Latest Holdings Summary
Pankaj Mohan currently owns a total of 2 stocks. Among these stocks, Pankaj Mohan owns 620,379 shares of Sonnet BioTherapeutics Holdings Inc (SONN) as of May 15, 2023, with a value of $1 Million and a weighting of 72.96%. Pankaj Mohan also owns 48,023 shares of Outlook Therapeutics Inc (OTLK) as of January 15, 2019, with a value of $379,382 and a weighting of 27.04%.
Latest Holdings of Pankaj Mohan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SONN | Sonnet BioTherapeutics Holdings Inc | 2023-05-15 | 620,379 | 1.65 | 1,023,625 |
| OTLK | Outlook Therapeutics Inc | 2019-01-15 | 48,023 | 7.90 | 379,382 |
Holding Weightings of Pankaj Mohan
Pankaj Mohan Form 4 Trading Tracker
According to the SEC Form 4 filings, Pankaj Mohan has made a total of 4 transactions in Sonnet BioTherapeutics Holdings Inc (SONN) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Sonnet BioTherapeutics Holdings Inc is the acquisition of 371,600 shares on May 15, 2023, which cost Pankaj Mohan around $81,752.
According to the SEC Form 4 filings, Pankaj Mohan has made a total of 0 transactions in Outlook Therapeutics Inc (OTLK) over the past 5 years. The most-recent trade in Outlook Therapeutics Inc is the acquisition of 50 shares on January 15, 2019, which cost Pankaj Mohan around $5,440.
Insider Trading History of Pankaj Mohan
- 1
Pankaj Mohan Trading Performance
GuruFocus tracks the stock performance after each of Pankaj Mohan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pankaj Mohan is -10.92%. GuruFocus also compares Pankaj Mohan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Pankaj Mohan within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Pankaj Mohan's insider trading performs compared to the benchmark.
Performance of Pankaj Mohan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 69.84 | | | | | |
| Relative Return to S&P 500(%) | 65.24 | | | | | |
Pankaj Mohan Ownership Network
Pankaj Mohan Owned Company Details
What does Sonnet BioTherapeutics Holdings Inc do?
Who are the key executives at Sonnet BioTherapeutics Holdings Inc?
Pankaj Mohan is the director & Chairman & President and CEO of Sonnet BioTherapeutics Holdings Inc. Other key executives at Sonnet BioTherapeutics Holdings Inc include 10 percent owner John Markey , Chief Technical Officer Susan Dexter , and Chief Medical Officer Richard T Kenney .
Sonnet BioTherapeutics Holdings Inc (SONN) Insider Trades Summary
Over the past 18 months, Pankaj Mohan made 2 insider transaction in Sonnet BioTherapeutics Holdings Inc (SONN) with a net purchase of 431,600. Other recent insider transactions involving Sonnet BioTherapeutics Holdings Inc (SONN) include a net purchase of 25,000 shares made by Nailesh Bhatt , a net purchase of 23,255 shares made by Albert D. Dyrness , and a net purchase of 10,000 shares made by Susan Dexter .
In summary, during the past 3 months, insiders sold 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) were sold and 489,855 shares were bought by its insiders, resulting in a net purchase of 489,855 shares.
Sonnet BioTherapeutics Holdings Inc (SONN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sonnet BioTherapeutics Holdings Inc Insider Transactions
Pankaj Mohan Mailing Address
Above is the net worth, insider trading, and ownership report for Pankaj Mohan. You might contact Pankaj Mohan via mailing address: C/o Sonnet Biotherapeutics Holdings, Inc, 100 Overlook Center, Princeton Nj 08540.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
